sodium salicylate has been researched along with thalidomide in 3 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (thalidomide) | Trials (thalidomide) | Recent Studies (post-2010) (thalidomide) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 9,789 | 1,385 | 4,342 |
| Protein | Taxonomy | sodium salicylate (IC50) | thalidomide (IC50) |
|---|---|---|---|
| Cereblon isoform 4 | Magnetospirillum gryphiswaldense | 7.8 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.37 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 0.5 | |
| DNA damage-binding protein 1 | Homo sapiens (human) | 1.38 | |
| Protein cereblon | Homo sapiens (human) | 1.38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROBSON, JM | 1 |
| FRASER, FC | 1 |
| Cachofeiro, V; Davel, AP; De Sá, LL; Fukuda, LE; Lahera, V; Munhoz, CD; Rossoni, LV; Sanz-Rosa, D; Scavone, C | 1 |
1 review(s) available for sodium salicylate and thalidomide
| Article | Year |
|---|---|
THE PROBLEM OF TERATOGENICITY.
Topics: Abnormalities, Drug-Induced; Congenital Abnormalities; Cyclizine; Female; Imipramine; Nicotine; Pregnancy; Pregnancy Complications; Research; Sodium Salicylate; Thalidomide; Toxicology | 1963 |
2 other study(ies) available for sodium salicylate and thalidomide
| Article | Year |
|---|---|
EXPERIMENTAL TERATOGENESIS IN RELATION TO CONGENITAL MALFORMATIONS IN MAN.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Bacterial Agents; Caffeine; Cortisone; Insulin; Lagomorpha; Meclizine; Mice; Oxytetracycline; Protein Synthesis Inhibitors; Rabbits; Rats; Research; Sodium Salicylate; Teratogenesis; Tetracycline; Thalidomide; Thyroxine; Toxicology | 1964 |
Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Aorta; Blotting, Western; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Injections, Subcutaneous; Interleukin-1beta; Interleukin-6; Isoproterenol; Male; NF-KappaB Inhibitor alpha; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Salicylate; Superoxide Dismutase; Thalidomide; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |